Cargando…
Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062523/ https://www.ncbi.nlm.nih.gov/pubmed/30050132 http://dx.doi.org/10.1038/s41467-018-05047-1 |
_version_ | 1783342386122850304 |
---|---|
author | Brochez, Lieve Meireson, Annabel Chevolet, Inès Sundahl, Nora Ost, Piet Kruse, Vibeke |
author_facet | Brochez, Lieve Meireson, Annabel Chevolet, Inès Sundahl, Nora Ost, Piet Kruse, Vibeke |
author_sort | Brochez, Lieve |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6062523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-60625232018-07-30 Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma Brochez, Lieve Meireson, Annabel Chevolet, Inès Sundahl, Nora Ost, Piet Kruse, Vibeke Nat Commun Correspondence Nature Publishing Group UK 2018-07-26 /pmc/articles/PMC6062523/ /pubmed/30050132 http://dx.doi.org/10.1038/s41467-018-05047-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Brochez, Lieve Meireson, Annabel Chevolet, Inès Sundahl, Nora Ost, Piet Kruse, Vibeke Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma |
title | Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma |
title_full | Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma |
title_fullStr | Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma |
title_full_unstemmed | Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma |
title_short | Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma |
title_sort | challenging pd-l1 expressing cytotoxic t cells as a predictor for response to immunotherapy in melanoma |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062523/ https://www.ncbi.nlm.nih.gov/pubmed/30050132 http://dx.doi.org/10.1038/s41467-018-05047-1 |
work_keys_str_mv | AT brochezlieve challengingpdl1expressingcytotoxictcellsasapredictorforresponsetoimmunotherapyinmelanoma AT meiresonannabel challengingpdl1expressingcytotoxictcellsasapredictorforresponsetoimmunotherapyinmelanoma AT chevoletines challengingpdl1expressingcytotoxictcellsasapredictorforresponsetoimmunotherapyinmelanoma AT sundahlnora challengingpdl1expressingcytotoxictcellsasapredictorforresponsetoimmunotherapyinmelanoma AT ostpiet challengingpdl1expressingcytotoxictcellsasapredictorforresponsetoimmunotherapyinmelanoma AT krusevibeke challengingpdl1expressingcytotoxictcellsasapredictorforresponsetoimmunotherapyinmelanoma |